SM_117b: Antidepressants Flashcards
Describe indications for antidepressants
Indications for antidepressants
- Generalized anxiety disorder: SSRIs, SNRI, TCA
- OCD: SSRIs, clomipramine
- Panic disorder: all antidepressants
- Social anxiety: SSRIs, SNRIs, MAOis
- PTSD: SSRIs, venlafaxine
- ADHD: buproprion
- Bulimia: SSRIs
- Premenstrual dysphoric disorder: SSRI, SNRIs
- Insomnia: mirtazapine, trazodone, TCAs
- Smoking cessation: bupropion
- Anxiety and depression symptoms in schizophrenia spectrum illness (with an antipsychotic)
- Anxiety and depression in bipolar (with mood stabilizer)
- IBS: SSRIs, TCAs
- Enuresis: imipramine
- Chronic pain especially neuropathic pain: TCAs, SNRIs
- Fibromyalgia: SNRIs
- Migraines; TCA (amitryptiline)
Monoamine theory of depression states ____
Monoamine theory of depression states underlying pathophysiologic basis of depression is a depletion in the levels of serotonin, norepinephrine, and/or dopamine in the CNS
____, ____, and ____ are monoamine neurotransmitters
Serotonin, norepinephrine, and dopamine are monoamine neurotransmitters
(NE and dopamine are catecholamines)
Describe the monoaminergic synapse
Monoaminergic synapse
- Monoamine NTs are synthesized within neurons from common precursors
- Synaptic vesicles take up NT via vesicular monoamine transporter
- On stimulation, vesicles within nerve terminal fuse with the presynaptic terminal and release NT into synaptic cleft
- Released NT interacts with postsynaptic receptors to alter function of postsynaptic cells
- Released NT acts on presynaptic autoreceptors in the nerve terminal to suppress further release
- Plasma membrane transporter proteins take NT from the synaptic cleft back up into the nerve terminal (aka reuptake)
- NT that was reuptaken is degraded or stored in vesicles
Describe treatment principles of antidepressants
Treatment principles of antidepressants
- Take 3-8 weeks to be maximally effective
- Have equivalent response rates and remission rates
- Placebo-drug differences are greatest in more severe depression
- Treat with goal of complete response
- Full relief requires adequate dose
- Switch to another first-line depressant if initial trial does not yield substantive improvement
- Add antidepressant of different class or target residual symptoms with other treatments if partial improvement at the maximally tolerated dose
Common reasons for lack of response include ____, ____, ____, and ____
Common reasons for lack of response include wrong diagnosis, inadequate dose, inadequate length of drug trial / not taking properly, refractory illness / psychiatric comorbidity / complex social stressors
Select first-line antidepressant based on ____, ____, and ____
Select first-line antidepressant based on side effect profile, past response to treatment, and comorbid medical and psychiatric problems
First-line antidepressants include ____, ____, ____, and ____
First-line antidepressants include SSRIs, SNRIs, mirtazapine, and bupropion
Describe common 5HT/NE side effects of antidepressants
Common 5HT/NE side effects of antidepressants
- GI upset (nausea, diarrhea)
- Anxiety, agitation
- Insomnia
- Headahce
- Sweating
- Sexual dysfunction
Serious risks of antidepressant treatment include ____, ____, and ____
Serious risks of antidepressant treatment include increased suicidal thinking / behavior, manic symptoms in people with undiagnosed bipolar disorder, and serotonin syndrome
Serotonin syndrome is a result of ____ often from ____
Serotonin syndrome is a result of increased 5-HT activity in the brain often from combining mutliple serotonergic drugs
Serotonin syndrome involves ____, ____, and ____
Serotonin syndrome involves mental status changes, autonomic hyperactivity, and neuromuscular abnormalities
MAOi is contraindicated with SSRI due to risk of ____
MAOi is contraindicated with SSRI due to risk of serotonin syndrome
Many antidepressants cause ____ symptoms when stopped
Many antidepressants cause withdrawal symptoms when stopped
Antidepressant classes include ____, ____, ____, ____, and ____
Antidepressant classes include
- Selective serotonin reuptake inhibitors
- Serotonin-norepinephrine reuptake inhibitors
- Tricyclic antidepressants
- Monoamine oxidase inhibitors
- Other